Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells (Q40599112)

21 September 2017

Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells (English)

1 reference

21 September 2017

Strang BL

1

1 reference

21 September 2017

Ikeda Y

2

1 reference

21 September 2017

Cosset FL

3

1 reference

21 September 2017

Collins MK

4

1 reference

21 September 2017

Takeuchi Y

5

1 reference

21 September 2017

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

7

1 reference

21 September 2017

591-598

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302189

21 September 2017

0 references

cites work

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

A stable system for the high-titer production of multiply attenuated lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Continuous high-titer HIV-1 vector production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Receptor interference groups of 20 retroviruses plating on human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Production and concentration of pseudotyped HIV-1-based gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Oncoretroviral and lentiviral vector-mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

7 January 2021

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

7 January 2021

Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

7 January 2021

Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

7 January 2021

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302189

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302189

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference